Medical and Vision Research Foundations, Sankara Nethralaya, Sankara Nethralaya, Chennai, Tamil Nadu, India.
Department of Vitreoretina, Medical and Vision Research Foundations, Sankara Nethralaya, Sankara Nethralaya, Chennai, Tamil Nadu, India.
Indian J Ophthalmol. 2022 Jun;70(6):2191-2194. doi: 10.4103/ijo.IJO_592_22.
A 28-year-old, healthy male presented with blurring of vision in the right eye following third dose of the AstraZeneca/COVISHIELD vaccine. Further examination revealed ischemic central retinal vein occlusion, and subsequent laboratory investigations were inconclusive for his eye disease. He responded to pulse corticosteroid and tapering doses of oral corticosteroids without requiring any intra-vitreal injection. Twelve articles were identified with the help of a PubMed literature search, and a short review of these patients was performed. Retinal vein occlusion can occur because of inflammation-induced thrombosis after coronavirus disease 2019 vaccination and may respond to anti-inflammatory therapy.
一位 28 岁健康男性在接种阿斯利康/科维希尔德第三针疫苗后出现右眼视力模糊。进一步检查显示为缺血性中央视网膜静脉阻塞，随后的实验室检查未能明确其眼部疾病的病因。他对脉冲皮质类固醇和逐渐减少剂量的口服皮质类固醇治疗有反应，无需任何玻璃体内注射。在 PubMed 文献检索的帮助下确定了 12 篇文章，并对这些患者进行了简短的回顾。视网膜静脉阻塞可能是由于 2019 年冠状病毒病疫苗接种后炎症引起的血栓形成引起的，并且可能对抗炎治疗有反应。
